Ticker Scorecard - RGEN Basics Company: Repligen Corporation IPO Date: March 26, 1990 Sector: Healthcare Industry: Life Sciences Tools and Services Market Cap: $8.91B Activated in VL: True Average Daily Range Avg Daily Range: $1.13 | 2.14% Avg Daily Range (30 D): $2.85 | 1.79% Avg Daily Range (90 D): $3.06 | 2.07% Institutional Daily Volume Avg Daily Volume: .28M Avg Daily Volume (30 D): .52M Avg Daily Volume (90 D): .48M Trade Size Avg Trade Size (Sh.): 74 Avg Trade Size (Sh.) (30 D): 39 Avg Trade Size (Sh.) (90 D): 39 Institutional Trades Total Inst.Trades: 5,395 Avg Inst. Trade: $4.82M Avg Inst. Trade (30 D): $6.38M Avg Inst. Trade (90 D): $6.62M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $6.7M Avg Closing Trade (30 D): $10.13M Avg Closing Trade (90 D): $10.58M Avg Closing Volume: 58.31K     News Feb 20, 2025 @ 4:25 PM Repligen's Q4 Slightly Tops Expectations Source: Jesterai Jan 9, 2025 @ 12:30 AM Chromatography System Market to Reach US$ 2.62 Bil... Source: Fact.Mr Dec 16, 2024 @ 1:11 PM BioLife Solutions Appoints Tony J. Hunt to its Boa... Source: Prnewswire Dec 12, 2024 @ 12:30 PM Repligen Announces Publication of the Companyâ€... Source: N/A Jun 26, 2024 @ 12:44 PM This Robinhood Analyst Turns Bullish; Here Are Top... Source: Avi Kapoor Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.09 $-.01 $.06 Diluted EPS $-.08 $-.01 $.06 Revenue $ 633.31M $ 154.87M $ 154.07M Gross Profit $ 314.09M $ 77.49M $ 76.76M Net Income / Loss $ -5.71M $ -.65M $ 3.32M Operating Income / Loss $ 12.43M $ -7.83M $ 1.49M Cost of Revenue $ 319.22M $ 77.38M $ 77.31M Net Cash Flow $ 157.53M $ -26.14M $ 29.02M PE Ratio